How about this one.

http://www.ripoffreport.com/r/Drew-Ciccarelli/Charleston-South-Carolina/Drew-Ciccarelli-dba-DMC-Capital-Investments-LLC-Portrayed-himself-as-owner-of-MusclePharm-1115926

You can't make this stuff up.

If the pps hits $12 you add as long as they say what they will do, and do what they said. If they give their guidance in Jan as expected and there is a runup to 12 you hold. Look to see over the next couple of days, weeks, months to hold them accountable for their actions. If you see that they are becoming credible, you add. If not, take your profits on half and monitor. I suspect that a run to $12 will happen before CYQ1 is over, maybe sooner. If they continue to hit the guidance then $15 might be in play by end of Q1. If we continue to ramp and get listed on Nasdaq we can go to $20 pretty quick. That would be an indication that all the BS is over. If we hit $154M in rev or greater like sandoti predicts and can get some profits out of it, watch out for $30 by end of year if not sooner. If we come out with new distribution that can get us to say $160M - $175M, the sky is the limit. It can all happen with some of our new partners guiding us.

Thanks. If they can get to profitability this year instead of next this will get to $30+ quickly.

Is there anyway to post the report or put a link out. I would love to see it. I missed the original report. Thanks.

I don't know. 87 catches almost 1,300 yards and 11 TD's. That does not sound too bad to me. Seems like a good guy to have on the team. He fits in perfect with Payton trowing the ball to 5 guys a game.

Anyone notice the interview on sports center with Eric Decker from the Broncos. He had on the big green MusclePharm MP on his shirt sleve.

Who is RenRen??

BTW, I think I mentioned this to JLTG a few days ago. If not just an fyi. MNKD is breaking out big time. .50c yesterday and now 1.10 today. This is huge and could be a $30-$50 stock. The ceo who is a self made billionaire predicted that their inhaled insulin drug will be the biggest selling drug of all time. Looking for FDA approval in April but something is driving this now. Maybe partnership before approval. This is the 3rd time going before the FDA for this and it looks like a slam dunk now.

Remember, the 1.2M shares is really on 600K. MSLP has the right to buy back 600K shares at $10 so with MSLP at $25 it is only 25 x 600K.

Biozone 8K is out with the merger details.

Someone help me with the math on this but here is what I think the potential is for Fuse with a lot of help from Frost/Opk, Macular and MSLP.

1. We have products on the market with major distributors as our partner. Walgreens.
2. We have major athletes on board. The best of the best.
3. We have major help from seasoned management who has turned around other struggling companies in the past. Ie. Frost with MSLP.
4. MSLP will hit 20-30 this year, then the sky is the limit.
5. What would drop do if over the next 2 years we are on a $50M runrate and then year 4 we are up to over a $100M in rev. MSLP did it.
6. So with 4M shares outstanding after the reverse split and fully diluted lets say we are now selling $25M? $50M? $75M? $100M? What is the stock price then.

This can happen and it may not take 4 years to get there. We have distribution. We have marketing. We lack $$$ to execute. My cost is at .10c for 500K shares. I believe I can get back to even by mid year or sooner and making money (lots of it) by end of the year and into the future.

Thoughts please.

JLTG, are they just trying to get it lower for the moment or something else. Looks like it wants to hang in and go higher. The trading in the stock is bizarre at best on any day.

I appreciate your insight. I have been guilty in the past of not pulling the sell trigger quick enough in the past. I have made huge amounts only to give it all back and then some of a few key positions. Got greedy. MNKD was one of those just recently. I seem to be able to pick a winner but I typically do not sell properly on a few. I go with the theory that if you have great management, great products at the right price you should do well. To me mslp has most of this but not great mgt. I am counting a lot on the Dr. Frost relationship to get them straight. Thus my large investment. I do have sells in for half my shares between $13-$15. Then make a decision on the rest as it goes. To me it could get there very quickly with the right news.

JLTG, want to pick your brain a bit.

I have a substantial holding in mslp, 8K at a cost around 9.5 I also have a new position in bzne of 30k shares at a new cost of .60 I have already taken a profit of $5K on bzne and about $30K of mslp several months ago.

I have not played a lot of penny stocks and just wonder exactly how you trade/play them. I am really not counting mslp as a penny but many still do here so I will add it in. What is your strategy for getting in and exiting. Is it after a certain profit, say 30% take 50% off and let the rest ride with a stop in place. Or is there some other magic that you use.

BTW, take a look at mnkd. It will have its day and it will be huge when it does.

So if everything you say comes true ( which I doubt ) where does that leave the contracts with the athletes? What happens to Tiger, Big Papi, Murray, etc. I would think that this would be very valuable to MSLP going forward.

So here is my prediction. You will see $10 before the end of January and you codie will stop posting out of embarrassment when it hits $12 before the end of Q1 or sooner.

MSLP names Pondel Wilkinson as Investor Relations Counsel. We go back to 10+ very fast.

Tont, how come there have been about 30 people on this board asking what you are doing here but you never answer them. How come? What is your motive for being here?

some big trades out there this morning. 776K on the bid. One trade for 550K already in the books.

Yes but if Dr. Frost is in charge of BZNE / Cocrystals and now a huge influencer of mslp he would want mslp to go up in value to help fund the new company (BZNE and CoCrys). They should be looking at selling their shares at $20 not $8. That is typical Dr. Frost. Just look at the recent opk sale of srne for a 900% profit.

Stupid question here. If a lot of us think that the news in Jan will be positive and many think we are undervalued why would there be this massive selling. Why isn't there a massive hold on the shares? Why would brad and whomever want to sell. Please help me with this thinking as it is very strange concept to me. If they are driving the shares down to pick it up at a lower level from weak hands then so be it. But selling by wynnfield or whoever they are, or brad does not make much sense to me. That is if we think this is a 14 stock in the next 6 months.

Arnold could positioned to ring the bell at the nasdaq uplifting if and when that takes place.

Arnie is a 5% guys. He will have to file when he sells.

tell me , have you ever seen merck do a buyout of a stock that is .025c or any other Fortune 500 company. That is a real long shot. We should just hope that they can get this back to .10c to get me back to even.

The only one to make an announcement that about share repurchases is the CEO. Not the CFO, not Cory, not a new hire. It is the CEO's responsibility. I would be more worried if it wasn't done this way.

They commit $5M over the next year to buy shares back on open market or pre arranged transaction with current shareholders. I wonder if that is how Cory will be selling his currently registered shares. Have the company buy them back, but at what price??

Nice jump of .54c is welcome relief. I hope it lasts.

Between the 4 of them about 25K shares or 21% of todays volume.

And so did Brad. Another 10K shares for him and 2K for Gary Lewis

Rodney and Cory just bought some stock. About 10K total shares. around $8 per share.

Someone bought ( and someone sold ) 31K at 8.15 a short while ago. Wonder what this is all about. Maybe Cory beginning to unload.

Why is everyone giving this guy so much airtime on this subject. If there was an issue it would be a major headline and the stock would be $2 and Dr. Frost would not be even close to it.

Brad just bought 9K more shares on the open market. I just got the alert on schwab. As high as 8.64 .

Long Vestor, thanks for the knowledge you are passing off to us. I for one appreciate it. If I could pick your brain a bit more and I know that some of the answers I am looking for are more opinions from you than fact. I personally do not believe that any of us have much info to go on to see where our drop stock may be in say 3 months, 6 months, or 1-2 years down the road.

As you look at this situation I am coming to the conclusion that you like to own the stock right here and possibly up to the .04c range that the warrant holders own at, is that correct.

As you look down the road, this stock will be littered with sellers as people need/want to get out as close to even as possible. So with that said we probably have some major overhangs at .06c, .07c, .10c and all the way up to .28c the latest most recent high. How do you think this plays out in the next 1-6 months. Is this a trade for you or are you looking for more out of the Frost, MSLP, BZNE, Honig, etc relationships to propel this to .50c - $1.00.

Just wondering what your overall thoughts are and strategy to make some money here.

Thanks in advance and I do appreciate everything you have done.

Rich

This is how I am thinking of it. Since BZNE sold most/all of it's assets to MSLP they are basically a shell company for Dr. Frost/TEVA Pharm to take Cocrystals without all the costs associated with doing it. Now once they merge a value will have to be put on the new company. What that is who knows? If they have 5 new products coming and the backing of Frost and Teva it must be big. Take a look at the management of Cocrystals. These are big time players as well. This could be a hidden gem at .70c. We will see but probably a great 2-3 year hold. Maybe we see this like an opko. Keep finding great technologies , add them in and watch them and the stock grow.

So what are you saying, buys MSLP???

I actually cannot post the link. It came from schwab and it will not allow me to copy the link or the actual post. Came out at 8am.

The headline is Biozone Pharmaceuticals Announces Executed Letter of intent to Merge with Cocrystals Discover Inc.

Very much so. See below.


Letters to Shareholders


COCRYSTAL DISCOVERY, INC.
September 19, 2011

To the Shareholders of Cocrystal Discovery, Inc.:

It is with great pleasure that I am providing this update on the progress of Cocrystal Discovery, Inc. We have just concluded a Research Collaboration Agreement, Exclusive License Option Agreement and a Share Purchase Agreement with Teva Pharmaceutical Industries Ltd. (NASDAQ:TEVA) whereby Teva may invest up to $45 million in Cocrystal.

Teva’s initial investment of $7.5 million will be utilized to continue our program, pursuant to the research agreement, to discover oral, once-a-day, broad-spectrum antiviral drug candidates that target the polymerase enzyme of Hepatitis C virus. Teva will have the option to invest an additional $7.5 million for further work on the HCV polymerase drug candidates and the right to an exclusive license for the results of the research under commercial terms. Teva also has the option to further invest similar amounts in Cocrystal for the development of drug candidates for two additional targets. According to the agreement, Teva could receive shares that will amount up to approximately a 23% holding in Cocrystal.

Nobel Laureate Roger Kornberg, Ph.D., Chief Scientist at Cocrystal, and also a Teva board member, commented, “We are delighted with this investment from Teva, a leading global company that develops important new medicines bringing value to patients. Through this agreement, Cocrystal is now ideally placed to accelerate the development of our novel platform, which combines high resolution X-ray crystallography with unique and advanced computational methods. It is our hope we can yield new and better drugs for the treatment and prevention of many viral diseases."

I am very pleased to begin working with Teva, one of the most successful pharmaceutical companies in the world. They bring great experience and knowledge in the marketplace to complement our drug discovery capabilities.

Sincerely,
Gary Wilcox
Chairman and CEO


About Hepatitis C

Hepatitis C is a serious liver disease caused by the hepatitis C virus, which is spread through direct contact with the blood of infected people and ultimately affects the liver. Chronic hepatitis C can lead to serious and life-threatening liver problems, including liver damage, cirrhosis, liver failure or liver cancer. More than 170 million people worldwide and approximately 4 million people in the United States are chronically infected with hepatitis C. Hepatitis C is the leading cause of liver transplantations in the United States and is reported to contribute to as many as 12,000 deaths annually. The Institute of Medicine of the U.S. National Academies estimates that by 2029, total annual medical costs in the United States for people with hepatitis C are expected to more than double, from $30 billion in 2009 to approximately $85 billion.

About Teva

Teva Pharmaceutical Industries Ltd. (NASDAQ:TEVA) is a leading global pharmaceutical company, committed to increasing access to high-quality healthcare by developing, producing and marketing affordable generic drugs as well as innovative and specialty pharmaceuticals and active pharmaceutical ingredients. Headquartered in Israel, Teva is the world's largest generic drug maker, with a global product portfolio of more than 1,300 molecules and a direct presence in 60 countries. Teva's branded businesses focus on neurological, respiratory and women's health therapeutic areas as well as biologics. Teva currently employs approximately 42,000 people around the world and reached $16.1 billion in net sales in 2010.

BZNE and Cocrystals merge. BZNE gets 40% of the company and Cocrystals gets 60%. Management at CoCrystal takes the lead. BZNE ask is up pre market to .74c up from .58c at yesterdays close.

Thank you Tontis. Where would we be without you. You are the next savior.

Form 144

This Form must be filed with the SEC by an affiliate of the issuer as a notice of the proposed sale of securities in reliance on Rule 144, when the amount to be sold under Rule 144 by the affiliate during any three-month period exceeds 5,000 shares or units or has an aggregate sales price in excess of $50,000. A person filing a Form 144 must have a bona fide intention to sell the securities referred to in the Form within a reasonable time after the filing of the Form.

Although the SEC does not require that the Form be sent electronically to the SEC’s EDGAR database, some filers choose to do so. You can learn how to use EDGAR to find the Form.

For more information, please read "Rule 144" in our Fast Answers databank.